25 May 2013
Keywords: latest, rnai, mega-deal, sees, takeda, team, up
Article | 02 June 2008
Alnylam Pharmaceuticals has entered a deal with Japan's largest drugmaker, Takeda, that could see the US RNA interference specialist
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 June 2008
24 May 2013
© 2013 thepharmaletter.com